Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 19 Sept 2017 for Cidara Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
No signal scores available.
Matthew Onaitis: trading record in brief
This profile gathers the share dealings of Matthew Onaitis across 3 companies, led by Somaxon Pharmaceuticals, Inc., Ignyta, Inc. and Cidara Therapeutics, Inc. We count 35 filings; the first trade dates from 8 October 2007 and the latest from 18 September 2017.
On the market, this insider has only sold: 8 sales, €428k in total. Besides market trades, the filings include 15 share grants and 11 option exercises.
On 19 September 2017 came the latest disclosure, a share grant in Cidara Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew Onaitis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
15,000 shares0Common StockSEC:0001209191-17-053302:0
26,400 sharesCommon StockSEC:0001209191-16-090812:0
20,000 shares0Common StockSEC:0001209191-15-003567:0
47,098 shares0Common StockSEC:0001354488-13-001066:0
1,494 shares0Common StockSEC:0001209191-13-001584:0
30,000 shares0Common StockSEC:0001209191-12-053988:0
15,716 shares0Common StockSEC:0001209191-12-047804:0
15,992 shares0Common StockSEC:0001209191-12-037001:0
9,000 shares@ US$0.4767Common StockSEC:0001209191-12-000914:0
30,000 shares0Common StockSEC:0001209191-11-016705:0
50,000 shares0Common StockSEC:0001209191-11-016705:1
30,000 shares0Common StockSEC:0001209191-10-020869:0
5,580 shares@ US$3.94Common StockSEC:0001209191-10-018096:0
2,627 shares@ US$7.00Common StockSEC:0001209191-10-018096:1
4,166 shares@ US$1.23Common StockSEC:0001209191-10-018096:2
17,945 shares@ US$1.23Common StockSEC:0001209191-10-018096:3
2,066 shares@ US$1.23Common StockSEC:0001209191-10-018096:5
1,111 shares@ US$1.23Common StockSEC:0001209191-10-018096:6
15,000 shares@ US$6.59Common StockSEC:0001209191-10-018096:7
14,454 shares@ US$9.00Common StockSEC:0001209191-10-018096:8
9,066 shares@ US$1.23Common StockSEC:0001209191-10-014258:0
20,934 shares@ US$1.23Common StockSEC:0001209191-10-014258:1
30,000 shares@ US$4.02Common StockSEC:0001209191-10-014258:2
25,000 shares@ US$1.23Common StockSEC:0001209191-10-007985:0
12,400 shares@ US$1.23Common StockSEC:0001209191-10-007985:1
25 of 31 declarations
